SARS-CoV-2 Omicron BA.4.6 resistant to many therapeutic monoclonal antibodies in clinical use
In a recent study posted to the bioRxiv* preprint server, researchers in Taiwan and the United States explore the resistance ...
In a recent study posted to the bioRxiv* preprint server, researchers in Taiwan and the United States explore the resistance ...
This article is forms part of a special issue on "research on prevention and control of emerging infectious diseases" https://www.sciencedirect.com/journal/biosafety-and-health/vol/4/issue/4. ...
In a recent article posted to the medRxiv* preprint server, researchers explored sotrovimab uptake for severe coronavirus disease 2019 (COVID-19) prophylaxis ...
In a recent study posted to the bioRxiv* preprint server, scientists identified an unmodified peptide addressing pre-hairpin spike (S) protein intermediate ...
The respiratory syncytial virus (RSV) is responsible for a third of pneumonia cases around the world and is the second ...
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in ...
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according ...
Treatments for multiple myeloma have grown a great deal in the past few years. Newer drugs help people with this blood cancer live longer and enjoy ...
In a recent study published in the Lancet, researchers evaluated the safety and efficacy of tixagevimab–cilgavimab, a severe acute respiratory ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net